These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33123276)

  • 1. Functional genetic variants of
    Li H; Chen L; Tong X; Dai H; Shi T; Cheng X; Sun M; Chen K; Wei Q; Wang M
    J Cancer; 2020; 11(23):6850-6860. PubMed ID: 33123276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional genetic variants of RUVBL1 predict overall survival of Chinese patients with epithelial ovarian cancer.
    Li H; Tong X; Xu Y; Wang M; Dai H; Shi T; Sun M; Chen K; Cheng X; Wei Q
    Carcinogenesis; 2019 Oct; 40(10):1209-1219. PubMed ID: 31083717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentially functional variants in nucleotide excision repair pathway genes predict platinum treatment response of Chinese ovarian cancer patients.
    Li H; Dai H; Shi T; Cheng X; Sun M; Chen K; Wang M; Wei Q
    Carcinogenesis; 2020 Sep; 41(9):1229-1237. PubMed ID: 32663249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional genetic variants of GEN1 predict overall survival of Chinese epithelial ovarian cancer patients.
    Li H; Wu J; Xu Q; Pang Y; Gu Y; Wang M; Cheng X
    J Transl Med; 2024 Jun; 22(1):577. PubMed ID: 38890669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in IGF2/H19 gene locus are associated with platinum-based chemotherapeutic response in Chinese patients with epithelial ovarian cancer.
    Zeng Y; Li TL; Zhang HB; Deng JL; Zhang R; Sun H; Wan ZR; Liu YZ; Zhu YS; Wang G
    Pharmacogenomics; 2019 Feb; 20(3):179-188. PubMed ID: 30672383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of single nucleotide polymorphisms in the MVP gene with platinum resistance and survival in patients with epithelial ovarian cancer.
    Zhao YN; He DN; Wang YD; Li JJ; Ha MW
    Oncol Lett; 2016 Apr; 11(4):2925-2933. PubMed ID: 27073578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the rs11614913 variant of miRNA-196a-2 and the risk of epithelial ovarian cancer.
    Song ZS; Wu Y; Zhao HG; Liu CX; Cai HY; Guo BZ; Xie YA; Shi HR
    Oncol Lett; 2016 Jan; 11(1):194-200. PubMed ID: 26870188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INSR gene polymorphisms correlate with sensitivity to platinum-based chemotherapy and prognosis in patients with epithelial ovarian cancer.
    Hu JL; Hu XL; Han Q; Guo AY; Wang CJ; Wen YY; Cang SD
    Gene Ther; 2017 Jul; 24(7):392-398. PubMed ID: 28436941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
    Permuth-Wey J; Fulp WJ; Reid BM; Chen Z; Georgeades C; Cheng JQ; Magliocco A; Chen DT; Lancaster JM
    Int J Cancer; 2016 Feb; 138(3):612-9. PubMed ID: 26264211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between polymorphisms of ERCC1 and survival in epithelial ovarian cancer patients with chemotherapy.
    Yan L; Shu-Ying Y; Shan K; Yip BH; Rong-Miao Z; Na W; Hai-Yan S
    Pharmacogenomics; 2012 Mar; 13(4):419-27. PubMed ID: 22329723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
    Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
    Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer.
    Moxley KM; Benbrook DM; Queimado L; Zuna RE; Thompson D; McCumber M; Premkumar P; Thavathiru E; Hines L; Moore KN
    Gynecol Oncol; 2013 Aug; 130(2):377-82. PubMed ID: 23632208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes.
    Li Y; Zhang HL; Kang S; Zhou RM; Wang N
    Gynecol Oncol; 2017 Jan; 144(1):140-145. PubMed ID: 27836206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling.
    Wu G; Cao L; Zhu J; Tan Z; Tang M; Li Z; Hu Y; Yu R; Zhang S; Song L; Li J
    Clin Cancer Res; 2019 Feb; 25(3):1022-1035. PubMed ID: 30279231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance.
    Mukherjee N; Dasgupta H; Bhattacharya R; Pal D; Roy R; Islam S; Alam N; Biswas J; Roy A; Roychoudhury S; Panda CK
    Biochim Biophys Acta; 2016 Sep; 1862(9):1472-84. PubMed ID: 27208794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer.
    Gagno S; Poletto E; Bartoletti M; Quartuccio L; Romualdi C; Garziera M; Scalone S; Sorio R; Dreussi E; Zanusso C; De Mattia E; Roncato R; Cecchin E; Giorda G; De Vita S; Dal Bo M; Puglisi F; Toffoli G
    Gynecol Oncol; 2020 Jan; 156(1):233-242. PubMed ID: 31711657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer.
    Steffensen KD; Waldstrøm M; Jeppesen U; Brandslund I; Jakobsen A
    Int J Gynecol Cancer; 2008; 18(4):702-10. PubMed ID: 17961161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.